Loading
UH
Universal Health Realty Income Trust Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 30 Oct 2025.
Universal Health Realty Income Trust: what insiders have been doing
Universal Health Realty Income Trust, classified in the Real Estate sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). Between 18 October 2025 and 18 October 2026, 5 insiders published 5 filings.
No insider sold shares on the market over the period. Instead, the filings list 1 purchase totalling €389k, made by 1 insider. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. On the buying side, the filings list 1 chief executive among the declarants. Miller Alan B filed the largest purchase, €389k, on 30 October 2025.
With 5 filings in twelve months, the company is quieter than the median of 19 filings across the 5,816 companies we follow on the same exchange. Over the whole record (from 2021), the tally stands at 11 purchases and no sales. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists revenue at 99.2 m USD and net income at 17.6 m USD; the dividend was 2.96 USD per share.
The most recent open-market purchase was published on 30 October 2025, 353 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4.
Elsewhere in the same sector, our signals recently picked up insider purchases at Agree Realty Corp and Simon Property Group Inc /DE/. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
65
Thresholds
n/a
Buy Volume
€2M
11 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleAlan B. Miller1 buy
Since the insiders bought
- +2.0%Entry US$38.22 · Close at T+90 US$38.99
- -20.2%Entry US$48.75 · Close at T+365 US$38.88
- -11.8%Entry US$57.87 · Close at T+365 US$51.02
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$37.54
Analyst consensus
1 analysts3.00/5
US$44.00Target US$44.00(+17%)US$44.00
Income statement
RevenueUS$99.2M
Gross profitUS$93.6M94% margin
EBITDAUS$67.6M68% margin
Net incomeUS$17.6M19.0% margin
Valuation
PER (trailing)27.0x
P/Book3.6x
Beta0.85
Balance sheet & cash
Market capUS$521.8M
Total debtUS$386M
Free Cash FlowUS$49.1M
Debt / Equity275%
Profitability & ownership
ROE12.5%
ROA4.1%
% insiders8.4%
% institutions63.4%
Last declaration on 11 June 2026
Declarations65 total
819 sharesShares Of Beneficial InterestSEC:0000798783-26-000013:0
3,631 sharesShares Of Beneficial InterestSEC:0000798783-26-000017:0
819 sharesShares Of Beneficial InterestSEC:0000798783-26-000006:0
819 sharesShares Of Beneficial InterestSEC:0000798783-26-000004:0
12,247 shares@ US$37.021732.9% of flowShares Of Beneficial InterestSEC:0000798783-25-000005:0
Canonical exit: 27 Jan 2026 (T+90)
1,540 shares0Shares Of Beneficial InterestSEC:0001127602-25-017372:0
3,499 shares0Shares Of Beneficial InterestSEC:0001127602-25-017370:0
821 shares0Shares Of Beneficial InterestSEC:0001127602-25-017357:0
3,499 shares0Shares Of Beneficial InterestSEC:0001127602-25-017367:0
6,021 shares0Shares Of Beneficial InterestSEC:0001127602-25-017365:0
821 shares0Shares Of Beneficial InterestSEC:0001127602-25-017362:0
821 shares0Shares Of Beneficial InterestSEC:0001127602-25-017360:0
821 shares0Shares Of Beneficial InterestSEC:0001127602-25-017353:0
821 shares0Shares Of Beneficial InterestSEC:0001127602-25-017352:0
821 shares0Shares Of Beneficial InterestSEC:0001127602-25-017351:0
350 shares@ US$40.26100.0% of flowShares Of Beneficial InterestSEC:0001127602-25-017085:0
785 shares0Shares Of Beneficial InterestSEC:0001127602-24-018056:0
785 shares0Shares Of Beneficial InterestSEC:0001127602-24-018053:0
3,536 shares0Shares Of Beneficial InterestSEC:0001127602-24-018068:0
3,536 shares0Shares Of Beneficial InterestSEC:0001127602-24-018073:0
785 shares0Shares Of Beneficial InterestSEC:0001127602-24-018049:0
1,556 shares0Shares Of Beneficial InterestSEC:0001127602-24-018078:0
785 shares0Shares Of Beneficial InterestSEC:0001127602-24-018041:0
6,083 shares0Shares Of Beneficial InterestSEC:0001127602-24-018063:0
785 shares0Shares Of Beneficial InterestSEC:0001127602-24-018051:0
25 of 65 declarations
About Universal Health Realty Income Trust
Universal Health Realty Income Trust (NYSE: UHT) is a U.S.-listed healthcare real estate investment trust focused on specialized medical and human-service properties. The trust began operations in 1986, originally by acquiring properties from subsidiaries of Universal Health Services (UHS) and immediately leasing them back to those operators. That founding structure still defines the business today: UHT is not a broad diversified property company, but a niche healthcare landlord built around long-duration leases, specialized assets, and a close historical relationship with UHS. Its headquarters are in King of Prussia, Pennsylvania, United States.
UHT’s portfolio is centered on acute care hospitals, behavioral health hospitals, medical office buildings, freestanding emergency departments, and a smaller number of assets tied to childcare, specialty uses, and other service-oriented facilities. In its 2024 annual report, the trust disclosed 76 real estate investments or commitments across 21 U.S. states, giving it a geographically broad footprint across the United States while remaining tightly focused on healthcare real estate. This mix gives the company some diversification by location, but its economics remain highly influenced by tenant quality, lease structure, and the operating performance of its key healthcare counterparties.
Read moreShow less
From a competitive standpoint, UHT occupies a relatively specialized corner of the REIT market. Its appeal lies in the defensive characteristics of healthcare property demand, supported by long-term demographic trends, recurring medical infrastructure needs, and the mission-critical nature of the underlying facilities. The company’s edge is not size, but specialization: it understands healthcare property economics, can structure transactions around complex operational assets, and has a long-standing relationship with UHS that supports lease visibility. Revenue is primarily generated through contractual rent, with some leases also including bonus rent linked to facility performance.
Recent filings indicate continuity rather than transformation. UHT renewed its advisory agreement for 2025 with a UHS subsidiary, and its first-half 2025 Form 10-Q shows that a meaningful portion of consolidated revenue still comes from UHS-related tenants. The company also reported second-quarter 2025 earnings on July 28, 2025. For investors, UHT is best viewed as a U.S. healthcare real estate vehicle listed on the NYSE, offering a defensive income profile and specialized asset exposure, but with notable concentration risk around a major operating partner.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
